Are you Dr. Rusnak?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 43 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1425 Porter St
Medical Division, Usamriid
Fort Detrick, MD 21702Phone+1 301-619-4156
Summary
- Dr. Janice Rusnak, MD is an infectious disease specialist in Fort Detrick, Maryland. She is currently licensed to practice medicine in Indiana.
Education & Training
Indiana University School of MedicineResidency, Internal Medicine, 1979 - 1982
University of Cincinnati College of MedicineClass of 1979
Certifications & Licensure
IN State Medical License 1982 - 2025- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Safety and Immunogenicity Study of Rift Valley Fever Vaccine Start of enrollment: 2004 Jun 01
- Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated Start of enrollment: 2009 Sep 01
- Treatment of Hemorrhagic Fever With Ribavirin Start of enrollment: 2022 Oct 31
Publications & Presentations
PubMed
- Safety and Immunogenicity of Accelerated Heterologous 2-Dose Ebola Vaccine Regimens in Adults With and Without HIV in Africa.Betty Mwesigwa, Fredrick Sawe, Janet Oyieko, Joel Mwakisisile, Edna Viegas
Clinical Infectious Diseases. 2024-10-15 - 16 citationsSafety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trialDavid K. Clarke, Rong Xu, Demetrius Matassov, Theresa E. Latham, Ayuko Ota-Setlik
The Lancet. Infectious Diseases. 2020-04-01 - 1 citationsDevelopment of a highly sensitive in vitro endothelial cell toxicity assay for evaluating ricin toxin A chain-based vaccines or therapeutics.Nicholas J. Machesky, Janice M. Rusnak, Evan H. Moore, Christopher B. Dorsey, Lucy A. Ward
Toxicon. 2019-09-01
